Garcia-Dorado D, Théroux P, Duran J M, Solares J, Alonso J, Sanz E, Munoz R, Elizaga J, Botas J, Fernandez-Avilés F
Servicio de Cardiologia, Hospital General Vall d'Hebron, Barcelona, Spain.
Circulation. 1992 Mar;85(3):1160-74. doi: 10.1161/01.cir.85.3.1160.
Myocardial reperfusion is associated with calcium overload and cell contracture, mechanisms that may precipitate cell death. In this study, we tested the hypothesis that in vivo inhibition of this contracture could lead to cell preservation in an open-chest large animal model.
Regional myocardium function was measured during a selective intracoronary infusion of 2,3-butanedione monoxime (BDM), a specific inhibitor of actin-myosin coupling, in the control state (10 pigs) and in a protocol of a 51-minute coronary occlusion followed by reperfusion (40 pigs). The effects on coronary artery blood flow in the basal state were also studied (seven pigs). Intramyocardial distribution of the infusate during coronary occlusion, myocardial water content after 30 minutes of reperfusion and area at risk, infarct size, type of histological necrosis, and infarct geometry after 24 hours of reperfusion were assessed. Methods used included electromagnetic flowmeter, radiolabeled microspheres, subendocardial sonomicrometers, fluorescein, triphenyl tetrazolium chloride and Masson's trichrome staining, and computer quantification of infarct edges. In the absence of ischemia, BDM infusion inhibited regional shortening in a dose-dependent manner up to full systolic bulging while producing marked regional increase in coronary blood flow. During early reperfusion, BDM reduced end-diastolic length 76% more than the control infusion (p less than 0.05) and increased systolic bulging by 420% compared with no change in control animals. The ratio of infarct size/area at risk was reduced by 31% with BDM (p less than 0.05), with striking modifications of infarct histology and infarct geometry; specifically, the extent of contraction band necrosis was reduced by 63% from 105.5 +/- 18.2 to 39.2 +/- 13.6 mm2 (p less than 0.02), and more patches of necrosis (6.5 +/- 2.1 versus 1.6 +/- 0.4, p less than 0.05) and higher contour (7.7 +/- 1.2 versus 5.03 +/- 0.2, p less than 0.05) and fractal (12.1 +/- 1.3 versus 7.8 +/- 0.2, p less than 0.05) indexes were found.
Selective intracoronary infusion of BDM at doses inhibiting regional wall motion decreased infarct size after reperfusion. The effects of BDM on regional function, the reduction in contraction band necrosis at histology, and the peculiar configuration of these infarcts all suggest that inhibition of contracture can interfere with cell-to-cell progression of myocardial necrosis, supporting a role for contracture in reperfusion-induced cell death.
心肌再灌注与钙超载和细胞挛缩有关,这些机制可能促使细胞死亡。在本研究中,我们检验了以下假设:在开胸大动物模型中,体内抑制这种挛缩可导致细胞保存。
在对照状态下(10头猪)以及在51分钟冠状动脉闭塞后再灌注的方案中(40头猪),在选择性冠状动脉内输注2,3 - 丁二酮单肟(BDM,一种肌动蛋白 - 肌球蛋白偶联的特异性抑制剂)期间测量局部心肌功能。还研究了基础状态下对冠状动脉血流的影响(7头猪)。评估冠状动脉闭塞期间灌注液在心肌内的分布、再灌注30分钟后的心肌含水量以及危险区域面积、梗死面积、组织学坏死类型和再灌注24小时后的梗死几何形状。使用的方法包括电磁流量计、放射性微球、心内膜下超声微测仪、荧光素、氯化三苯基四氮唑和Masson三色染色,以及梗死边缘的计算机定量分析。在无缺血情况下,BDM输注以剂量依赖性方式抑制局部缩短,直至完全收缩期膨出,同时使冠状动脉血流显著局部增加。在早期再灌注期间,BDM使舒张末期长度比对照输注减少76%(p<0.05),与对照动物无变化相比,收缩期膨出增加420%。BDM使梗死面积/危险区域面积的比值降低31%(p<0.05),梗死组织学和梗死几何形状有显著改变;具体而言,收缩带坏死范围从105.5±18.2减少至39.2±13.6 mm²,减少了63%(p<0.02),并且发现更多坏死灶(6.5±2.1对1.6±0.4,p<0.05)以及更高的轮廓(7.7±1.2对5.03±0.2,p<0.05)和分形(12.1±1.3对7.8±0.2,p<0.05)指数。
以抑制局部室壁运动的剂量选择性冠状动脉内输注BDM可减少再灌注后的梗死面积。BDM对局部功能的影响、组织学上收缩带坏死的减少以及这些梗死的特殊形态均表明,挛缩抑制可干扰心肌坏死的细胞间进展,支持挛缩在再灌注诱导的细胞死亡中的作用。